You’d think a stock that’s already surged over 600% in five years might have run out of steam. But according to analysts at Anand Rathi, one high-flying healthcare stock might just be getting started. They believe there’s still up to 40% more upside—and not just because of the numbers. There’s a story unfolding behind the scenes.
The stock in focus is Indraprastha Medical Corporation Ltd., a name that’s quietly turned early investors into millionaires. Its share price has jumped more than sixfold since 2019, with gains of nearly 70% in the last year alone. And yet, Anand Rathi’s research team says the rally may not be over.
So What’s Fueling This New Optimism?
There’s one major reason this stock is back in the headlines: a potential stake sale by the Delhi government. The state owns 26% of Indraprastha Medical, and there’s speculation that it may soon offload its share. If that happens—and if the company’s promoters are the ones who buy it—it could reshape the way the hospital group is run.
More control for promoters could mean faster decisions, more aggressive expansion, and fewer bureaucratic hurdles. That’s why analysts are excited. It’s not just about who owns the stock, but what they’ll do with it if they take the reins.
Big Plans on the Ground, Too
It’s not just boardroom moves that have investors buzzing. Indraprastha Medical is in the middle of a major expansion. At its main hospital in Sarita Vihar, Delhi, the company is planning to more than double its bed capacity, adding over 900 new beds by 2028.
That’s part of a ₹580 crore project that will also add massive parking capacity—something most city hospitals desperately need. The rollout will happen in phases, with about 40% of the spending expected in 2026 and the rest in the following two years.
If the project goes as planned, it could make Sarita Vihar one of the largest hospital campuses in the country. That’s not just good for patients—it’s potentially great for long-term revenue growth.
What Analysts Are Saying
Anand Rathi now values the stock at ₹590 per share, which is roughly 40% higher than where it’s trading today. That target takes into account both the stake sale speculation and the major expansion plans.
Even with a 600% gain in the rear-view mirror, analysts think there’s room for more—especially if the company executes its growth plans well and the ownership structure becomes more streamlined.
But It’s Not Without Risk
Of course, nothing is guaranteed. The stake sale hasn’t been finalized, and big expansion projects like this are always vulnerable to cost overruns or delays. Plus, the healthcare sector in India is competitive, with many hospital chains jostling for space and patients in urban markets.
There’s also the regulatory factor—healthcare is tightly controlled, and changes in policy or pricing structures could affect profitability.
Why This Stock Still Stands Out
What makes Indraprastha’s story compelling is how it’s evolving. This isn’t just a small hospital that got lucky. It’s growing, reinvesting, and potentially entering a new chapter where it could operate with more freedom and speed.
For analysts like those at Anand Rathi, that means the stock may not just keep climbing—it could be revalued entirely if market confidence grows.
